Literature DB >> 90569

Dual response of lymphocytes from multiple sclerosis patients to myelin basic protein.

V Wicher, W Olszewski, F Milgrom.   

Abstract

Peripheral blood lymphocytes from forty-nine patients with multiple sclerosis (MS), twelve patients with other neurological diseases and twenty-seven healthy individuals were examined by a two-stage procedure based on the Con A stimulation of the basic protein (BP) pre-treated lymphocytes. Enhanced BP-induced blastogenic stimulation (BS) (90--220% was observed in MS individual classified as active (A-MS), whereas suppressed BS (27--120%) was observed in MS patients classified as non-active (NA-MS). The difference was statistically significant (P less than 0.01). The results obtained with the MS patients' lymphocytes also differed significantly (P less than 0.05) from those of the two control groups. Either response obtained with MS lymphocytes could be elicited with a similar concentration of BP. The enhanced or suppressed response to BP did not correlate with the cellular response to common antigens such as candida and streptokinase-streptodornase. Most lymphocytes of individuals from the two control groups showed BS values of 100 +/- 20% in response to BP. However, some degree of stimulation or suppression was also obtained with lymphocytes from a few individuals of both control groups. The potential value and application of the two-stage procedure is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90569      PMCID: PMC1537667     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  A contribution to the classification and the pathogenesis of demyelinating encephalomyelitis; with special reference to the central nervous system lesions caused by preventive inoculation against rabies.

Authors:  I UCHIMURA; H SHIRAKI
Journal:  J Neuropathol Exp Neurol       Date:  1957-04       Impact factor: 3.685

Review 2.  Cellular immunity in multiple sclerosis.

Authors:  S C Knight
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

Review 3.  Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  I R Mackay; P R Carnegie; A S Coates
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

4.  Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases.

Authors:  D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

5.  Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents.

Authors:  U Youngchaiyud; A S Coates; S Whittingham; I R Mackay
Journal:  Aust N Z J Med       Date:  1974-12

6.  Lymphocytes binding basic protein of myelin; cytophilic serum antibody and effect of adjuvant.

Authors:  A S Coates; V A Lennon
Journal:  Immunology       Date:  1973-03       Impact factor: 7.397

7.  New concept of critical steps in course of chronic debilitating neurologic disease in evaluation of therapeutic response; a longitudinal study of multiple sclerosis by quantitative evaluation of neurologic involvement and disability.

Authors:  L ALEXANDER
Journal:  AMA Arch Neurol Psychiatry       Date:  1951-09

8.  Antigen-binding lymphocytes in normal man and guinea pig to human encephalitogenic protein.

Authors:  L L Yung; E Diener; T A McPherson; M A Barton; H A Hyde
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

9.  Autoimmune and virus-induced demyelinating diseases. A review.

Authors:  P W Lampert
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

10.  Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. II. Evidence for separate stimulatory and inhibitory cells.

Authors:  R W Dutton
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  1 in total

1.  SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens.

Authors:  Chandirasegaran Massilamany; Francine Marciano-Cabral; Bruno da Rocha-Azevedo; Melissa Jamerson; Arunakumar Gangaplara; David Steffen; Rana Zabad; Zsolt Illes; Raymond A Sobel; Jay Reddy
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.